Carregant...
Novel targeted therapeutics for metastatic castration-resistant prostate cancer
Virtually all patients that succumb to prostate cancer die of metastatic castration-resistant disease. Although docetaxel is the standard of care for these patients and is associated with a modest prolongation of survival, there is an urgent need for novel treatment strategies for metastatic prostat...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029098/ https://ncbi.nlm.nih.gov/pubmed/19717225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2009.08.012 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|